Skip to main content

J&J To Pay More Than $400 M To Resolve Hip Device Suits

J&J To Pay More Than $400 M To Resolve Hip Device Suits

J&J To Pay More Than $400 M To Resolve Hip Device Suits

Introduction

Johnson & Johnson recently agreed to pay more than $400 million to settle some product liability cases concerning Pinnacle hip-replacement devices. The officials indicated an average of about $125,000 per case to resolve about 3,300 lawsuits pending against the company over design defects in the Pinnacle hip system.

The settlement would resolve a large chunk of cases from the hip implant litigation which involves claims from several patients who were affected by the metal poisoning from the defective hip implants which were taken off the market in 2013. The remaining cases would be settled before a trial which is underway on January 14, 2019, in Dallas. The Pinnacle hip lawsuits are consolidated before U.S. District Judge Ed Kinkeade since 2011 (MDL 3:11-MD-02244, In Re: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation) in the Northern District of Texas.

More than 11,000 lawsuits over ASR and Pinnacle hip implant defects are filed against DePuy. Similar lawsuits are filed against other manufacturers in the U.S. involving defendants Zimmer, Stryker, Biomet, Wright, and Smith & Nephew.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!